ABBVIE INC. vs. Regeneron Pharmaceuticals Inc
ABBVIE INC. (ABBV) comes out ahead, leading on 3 of 3 compared factors.
Size & Scale
| ABBV | REGN | |
|---|---|---|
| Market Cap | $521.41 billion | $94.76 billion |
ABBV leads on 1 of 1 size & scale factors.
Dividend
| ABBV | REGN | |
|---|---|---|
| Dividend Yield | 2.47% | 0.39% |
ABBV leads on 1 of 1 dividend factors.
Risk & Sentiment
| ABBV | REGN | |
|---|---|---|
| Short Interest | 0.85% | 1.82% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, REGN overview, REGN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.